Clinical Trials Browser

OTHER × Testicular Neoplasms × cabazitaxel × Clear all

NCT02478502 2024-02-02

Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer

Phase 2 Terminated

Testicular Neoplasms